Coretti S - Search Results

1

Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review.

Ruggeri M, Manca A, Coretti S, Codella P, Iacopino V, Romano F, Mascia D, Orlando V, Cicchetti A. Ruggeri M, et al. Among authors: coretti s. Value Health. 2015 Jul;18(5):709-20. doi: 10.1016/j.jval.2015.03.1795. Value Health. 2015. PMID: 26297100 Free article. Review.

2

Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy.

Coretti S, Ruggeri M, Codella P. Coretti S, et al. Value Health. 2014 Nov;17(7):A511. doi: 10.1016/j.jval.2014.08.1572. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201575 Free article. No abstract available.

3

Economic assessment of an anti-HCV screening program in Italy.

Ruggeri M, Coretti S, Gasbarrini A, Cicchetti A. Ruggeri M, et al. Among authors: coretti s. Value Health. 2013 Sep-Oct;16(6):965-72. doi: 10.1016/j.jval.2013.07.005. Value Health. 2013. PMID: 24041346 Free article.

4

Do Probability and Certainty Equivalent Techniques Lead to Inconsistent Results? Evidence from Gambles Involving Life-Years and Quality of Life.

Ruggeri M, Coretti S. Ruggeri M, et al. Among authors: coretti s. Value Health. 2015 Jun;18(4):413-24. doi: 10.1016/j.jval.2014.12.019. Epub 2015 Apr 15. Value Health. 2015. PMID: 26091595 Free article.

5

Economic assessment of eltrombopag in the treatment of thrombocytopenia.

Romano F, Ruggeri M, Coretti S, Giannini EG, Sacchini D, Annichiarico BE, Marchetti M, Rodeghiero F, Lidonnici D. Romano F, et al. Among authors: coretti s. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):713-20. doi: 10.1586/14737167.2015.1028373. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 26176754

6

COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONS.

Coretti S, Codella P, Romano F, Ruggeri M, Cicchetti A. Coretti S, et al. Int J Technol Assess Health Care. 2016 Jan;32(4):233-240. doi: 10.1017/S0266462316000337. Epub 2016 Sep 14. Int J Technol Assess Health Care. 2016. PMID: 27624398

7

Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort.

Ruggeri M, Coretti S, Romano F, Kondili LA, Vella S, Cicchetti A. Ruggeri M, et al. Among authors: coretti s. Value Health. 2018 Jul;21(7):783-791. doi: 10.1016/j.jval.2017.10.021. Epub 2017 Dec 6. Value Health. 2018. PMID: 30005750 Free article.

8

Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.

Ruggeri M, Basile M, Coretti S, Drago C, Cicchetti A. Ruggeri M, et al. Among authors: coretti s. Appl Health Econ Health Policy. 2017 Aug;15(4):479-490. doi: 10.1007/s40258-017-0311-4. Appl Health Econ Health Policy. 2017. PMID: 28197805

9

The minimum clinically important difference for EQ-5D index: a critical review.

Coretti S, Ruggeri M, McNamee P. Coretti S, et al. Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33. doi: 10.1586/14737167.2014.894462. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24625040 Review.

10

Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature.

Coretti S, Romano F, Orlando V, Codella P, Prete S, Di Brino E, Ruggeri M. Coretti S, et al. Risk Manag Healthc Policy. 2015 Apr 21;8:45-54. doi: 10.2147/RMHP.S56911. eCollection 2015. Risk Manag Healthc Policy. 2015. PMID: 25960681 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters